BioXcel Therapeutics earnings missed by $0.07, revenue fell short of estimates
Reported by Investing.com · investing.com ·
Story context
What to watch: BTAI (BTAI) missed estimates by roughly $0.07 — watch for guidance cuts, which often follow a miss this size.
How this was labelled
Investing.com published this one, and Wook filed it under Earnings. The automated reading is bearish, at medium severity. Both of those labels come from matching words in the headline and preview against a fixed list. No editor and no AI is involved, which keeps them consistent and also keeps them blunt: they describe how the story is worded, not what it will do. It was matched to $BTAI. Matching works by reading symbols and company names out of the text, which means a company mentioned in passing gets tagged the same way as the one the story is about. The headline or preview carried 1 figure — $0.07 — shown above exactly as published. Nothing was recalculated. The publisher gave no preview text for this story, so only the headline appears above. Nothing has been written in to fill the gap.
When it landed
This one landed outside trading hours, so the session change shown beside it belongs to a day that had already closed. It is worth keeping the two apart: the price next to a story and the story itself run on different clocks. The publication time is whatever the publisher stamped on it. Weekends are taken into account here; market holidays are not.
What this page is not saying
The tone and severity labels come from keyword matching. They are not a forecast, not a member vote, and not a recommendation. Any figures are copied from the headline or preview rather than worked out here, and a price move on the same day does not mean this story caused it. None of this is investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.